[Management of enzalutamide, a new hormonal therapy].

Abstract:

:Enzalutamide (MDV3100) is a non-steroidal antiandrogen of second generation that has shown efficacy in metastatic castration-resistant prostate cancer (mCRPC). The study AFFIRM demonstrated a statistically significant increase in overall survival among patients who have progressed following a docetaxel chemotherapy. Based on these results, a marketing authorization for enzalutamide has been granted. The enzalutamide has been shown to be generally well tolerated. Other trials are underway to evaluate its earlier use in the management of mCRPC. A pivotal registration phase III study (PREVAIL) is ongoing to investigate the effectiveness of enzalutamide in patients who have not yet received chemotherapy.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Beuzeboc P,Benderra MA,de La Motte Rouge T

doi

10.1684/bdc.2013.1880

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

107-12

issue

1

eissn

0007-4551

issn

1769-6917

pii

bdc.2013.1880

journal_volume

101

pub_type

杂志文章
  • [News of the year 2005 in sarcomas].

    abstract::This year, the innovations were numerous in sarcomas. Important progress were accomplished in the search for predictive factors which make it possible to propose to the patient a personalized treatment with the therapeutic ones reduced in the event of good prognosis or on the contrary aggressive steps in the event of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Fayette J,Méeus P,Sunyach MP,Thiesse P,Ray Coquard I,Blay JY

    更新日期:2006-01-01 00:00:00

  • [Spontaneous transformation and long term culture of foetal mouse glial cells (author's transl)].

    abstract::Six cell lines originated from foetal mouse brain were maintained in vitro for more than two years. The morphology of most of these cultures suggests their glial character. This is corroborated, for some lines, by the presence of specific glial protein (Glial fibrillary acidic protein, or GFAP). Five out of these line...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Coulomb B,Levy S,Maunoury R,Markovits P

    更新日期:1979-01-01 00:00:00

  • [Nasopharyngeal epitheliomas: experience of the Regional Cancer Control Center in Lille (79 cases 1970-1982)].

    abstract::From 1970 to 1982, 79 cases of nasopharyngeal carcinomas were treated at the Regional Cancer Center of Lille (France). At the term of the study, it appears that patients of Central Europe origin have a rather high risk of NPC (17% of cases, that ethnic population representing about 8% of all superior aerodigestive tra...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lefebvre JL,Madelain M,Adenis L,Demaille MC,Delobelle A,Demaille A

    更新日期:1983-01-01 00:00:00

  • Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve.

    abstract:BACKGROUND:The standard treatment in first line of advanced or metastatic urothelial bladder cancer (MBC) is the association of Gemcitabine and Cisplatin (GC). Avelumab, an anti-PD-L1 agent, has recently demonstrated efficacy. The objective is to evaluate the combination of these 3 agents. METHODS:This phase II random...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30280-0

    authors: Gross-Goupil M,Domblides C,Lefort F,Ravaud A

    更新日期:2020-06-01 00:00:00

  • [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].

    abstract::Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) is now an entire part of treatment of peritoneal dissemination of colorectal malignancy, and it's possible to hope prolonged survival. This treatment is more and more codified. Four indications are recognized by some tree national evaluation committees: ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0553

    authors: Eveno C,Dagois S,Guillot E,Gornet JM,Pocard M

    更新日期:2008-01-01 00:00:00

  • [Mechanisms and role of lymphangiogenesis in cancer metastasis].

    abstract::An important critical point in tumor progression is the acquisition of metastatic potential. The presence of metastases in regional lymph nodes is an indicator of poor survival. The vascular endothelial growth factor (VEGF) family of growth factors and receptors is involved in vasculogenesis and angiogenesis. Among th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dupuy E,Tobelem G

    更新日期:2003-07-01 00:00:00

  • [Proton therapy in soft tissue and bone sarcomas].

    abstract::Sarcomas are a common type of tumor within the pediatric population. The utilization of proton therapy as a primary attribute the ability to spare adjacent healthy tissue, therefore, proton therapy has become a preferential indication in pediatrics compared to other photon irradiation modalities. Proton therapy is als...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.05.008

    authors: Thariat J,Tessonnier T,Bonvalot S,Lerouge D,Mammar H,Bolle S,Claren A,Duffaud F,Alapetite C,Vogin G

    更新日期:2018-09-01 00:00:00

  • [Cancer of the uterine cervix in young women. A retrospective study of 337 cases].

    abstract::A retrospective study of 337 cases of cervix cancers in women aged 35 years and under, treated between 1980-1990 at the Ibn Rochd Oncology Center in Casablanca, was analyzed in order to determine the main characteristics of this disease and the influence of age on prognosis. The incidence of these cases was stable thr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Acharki A,Sahraoui S,Benider A,Tawfiq N,Jouhadi H,Bouras N,Samlali R,Kahlain A

    更新日期:1997-04-01 00:00:00

  • [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].

    abstract::For most diseases, one observes great variability in clinical course and response to therapy which should be taken into account in the design and the analysis of clinical trials. Eligibility criteria and stratified randomization use prognostic knowledge. A suitable analysis of randomized studies includes: (1) checking...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Byar D,Chastang C

    更新日期:1987-01-01 00:00:00

  • [Secondary non-Hodgkin's lymphomas].

    abstract::Developing a secondary non Hodgkin's lymphoma (NHL) more than 12 months after treatment for first cancer, is uncommon. Secondary NHL occurs sometimes after chronic lymphatic leukemia or Hodgkin's disease. The 20 years cumulative incidence rate is 3-5% after Hodgkin's disease. Secondary NHL seems less frequent after an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Cappelaere P

    更新日期:1998-03-01 00:00:00

  • [Angiogenin: involvement in angiogenesis and tumour growth].

    abstract::Angiogenin is one of the most potent inducers of neovascularization in experimental models in vivo. Angiogenin is normally present in plasma but overexpressed in cancer patients. The possible involvement of angiogenin in the development of cancer is suggested by its overexpression in patients with a variety of tumours...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Pavlov N,Badet J

    更新日期:2001-08-01 00:00:00

  • [Statistical study of a series of 672 cases of carcinoma of the uterine cervix. Results and complications according to age and modalities of treatment].

    abstract::The study bears on 672 infiltrating carcinomas of the cervix treated from 1977 until the end of 1991, by a radiosurgical combination (311 patients) or by exclusive irradiation (361 patients). The radiosurgical series includes mostly stages IB and II and patients under 50 years because of the therapeutic protocol. Most...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Pernot M,Hoffstetter S,Peiffert D,Carolus JM,Guillemin F,Verhaeghe JL,Marchal C,Luporsi E,Beckendorf V,Stines J

    更新日期:1995-07-01 00:00:00

  • An ethics dilemma: when parents and doctors disagree on the best treatment for the child.

    abstract::The increasing complexity of present day medicine--with highly effective and yet risky treatments, individual and collective expectations, and evolving ideological and cultural landmarks--often gives rise to difficult ethical problems. Specific meetings are valuable for understanding such problems, acquiring the relev...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Oppenheim D,Brugières L,Corradini N,Vivant F,Hartmann O

    更新日期:2004-09-01 00:00:00

  • [Risk of stage underestimation of breast cancer by sentinel lymph node biopsy method].

    abstract::Sentinel lymph node (SLN) biopsy is fast becoming the standard for testing lymph node involvement in many institutions. However questions remain as to stage underestimation. The aim of this study was to analyse this specific risk in a retrospective study. Between 1975 to 1999, 1,636 patients underwent a breast cancer ...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Houvenaeghel G,Martino M,Jacquemier J,Moutardier V,Tallet A,Viens P,Puig B,Bardou VJ

    更新日期:2003-05-01 00:00:00

  • [Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects].

    abstract::Cerebral non Hodgkin's lymphomas (NHL) of immunocompetent patients are rare disease (1% of all NHL), but their incidence has been steadily increasing in the last 20 years. Most cerebral NHL are diffuse large cell NHL with a B phenotype. These tumors are most often localized in the central nervous system, the eye or me...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,meta分析

    doi:

    authors: Blay JY

    更新日期:1997-10-01 00:00:00

  • [Consultations in oncological supportive care mono-, multi-, ou interdisciplinary: What should we favour?].

    abstract::According to the point 7.6 and 7.7 of the Cancer Plan 2014, all cancer patients should have access to supportive care. Indeed, the supportive care consultation in oncology is an important tool for the symptom management of cancer patients at all times of treatment. This consultation can be mono-disciplinary or multi-d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.04.019

    authors: Garnier SR,Pelletti C,Quenard C,Vallet F,Lemoine P,Guastella V,Rhondali W

    更新日期:2015-09-01 00:00:00

  • [Not Available].

    abstract:SURGICAL DE-ESCALATION FOR INVASIVE BREAST CANCER TREATMENT:A surgical therapeutic de-escalation is going to continue but necessarily has to design in a progressive careful way and especially arranged with the other practitioners and therapeutic methods. These strategies concern as well the surgery of the breast as tha...

    journal_title:Bulletin du cancer

    pub_type: 社论

    doi:10.1016/S0007-4551(16)30151-5

    authors: Houvenaeghel G,Cohen M,Bannier M,Jauffret C,Buttarelli M,Lambaudie E

    更新日期:2016-06-01 00:00:00

  • [Malignant cardiac tumors].

    abstract::Cardiac neoplasms are a rare occurrence in clinical practice. The various frequencies of primary and secondary malignant tumors vary from report to report, approximately 1% in most autopsy series and 4% in cancer patient's autopsies. Cardiac malignancies account for less 1% of cardiac surgery and about for 0.1% of car...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Debourdeau P,Gligorov J,Teixeira L,Aletti M,Zammit C

    更新日期:2004-11-01 00:00:00

  • [Announcing cancer diagnosis: which communication difficulties from professional and from patient's side? Which possible improvements?].

    abstract::Announcing a cancer diagnosis, but also a relapse, a progression of the disease, or transition towards palliative care constitute particularly difficult communication issues for the patient as well as for the clinician, during the trajectory of care. The objectives of this article is to present the clinical stakes of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1197

    authors: Dolbeault S,Brédart A

    更新日期:2010-10-01 00:00:00

  • [Aprepitant for the prevention of cisplatine induced nausea and vomiting: an observational study].

    abstract::Aprepitant is actually recommended in the prevention of nausea and vomiting induced by high emetic risk chemotherapy using cisplatin. We performed an observational prospective study on 101 patients evaluating the efficacy of aprepitant in the clinical conditions of use of cisplatin, out of context of clinical trial. W...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2008.0819

    authors: Galy G,Labidi SI,Tissier F,Combes JD,Auger A,Favier B,Latour JF

    更新日期:2009-02-01 00:00:00

  • [Small cell carcinoma. Incidence, histopathology and anatomical features. Analysis of 465 autopsied bronchopulmonary carcinomas (author's transl)].

    abstract::465 patients with broncho-pulmonary malignant tumors have been autopsied. Small cell carcinoma was diagnosed in 22.5 per cent of these patients. The histo-cytological variants of these tumors (lymphocytoid, polygonal, fusiform and polymorphic) had the same general characteristics (age, sex, survival) and a similar cli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Chomette G,Auriol M,Tranbaloc P,Esperandieu O,Guettier C

    更新日期:1982-01-01 00:00:00

  • Similarity in morphological appearance of cycling and resting hemopoietic stem cells.

    abstract::The morphological entity which has been identified previously as the most likely candidate for the pluripotential hemopoietic stem cell in mouse bone marrow, has been encountered in HSC concentrates of rat bone marrow. An identical correlation between percentage of HSC identified in electron microscopical preparations...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: van Bekkum DW,Knaan S

    更新日期:1978-01-01 00:00:00

  • [Attachment and caregivers' life course facing cancer].

    abstract:INTRODUCTION:Since the last cancer plan 2014-2019, the assessment of the impact of the disease on caregivers became essential. The quality of caregiving represents an important part of the patient's quality of life. The main objective was to describe the evolution of caregiver's attachment style during the first three ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.08.011

    authors: Bonnet M,Vadam F,Belot RA,Quibel C,Pozet A,Nerich V

    更新日期:2020-11-01 00:00:00

  • [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

    abstract::Haploidentical hematopoietic stem cell transplantation (HSCT) is being increasingly used due to improvement of the transplantation procedures allowing a reduction of graft-versus-host-disease (GVHD) and of transplant-related mortality (TRM). Such improvements have been particularly observed after administration of T-r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2016.09.007

    authors: Nguyen S,Chalandon Y,Lemarie C,Simon S,Masson D,Dhedin N,Suarez F,Renaud B,Charbonnier A,Yafour N,François S,Duléry R,Blaise D,Yakoub-Agha I,Rubio MT

    更新日期:2016-11-01 00:00:00

  • [External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients].

    abstract::This study is concerning 70 patients (57 female, 13 male) with an epidermoid carcinoma of the anal canal which were treated homogeneously with a combination of an external beam radiation therapy ((45 Gy in 25 fractions of 1.8 Gy for 5 weeks) and a brachytherapy with Iridium wires (15 to 20 Gy delivered to the gross re...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Dubois JB,Azria D,Ychou M

    更新日期:2003-12-01 00:00:00

  • [Role of [18F]-FDG PET-CT in the management of the head and neck cancers].

    abstract:OBJECTIVES:To evaluate the impact of [(18)F]-FDG PET/CT image fusion in the management of carcinomas of the upper aero-digestive tract. METHODS:This retrospective study included 169 patients with squamous cell cacinoma of the upper aerodigestive tract who underwent a PET/CT for : initial staging (n = 47), cervical lym...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Fakhry N,Barberet M,Lussato D,Cammilleri S,Mundler O,Giovanni A,Zanaret M

    更新日期:2006-10-01 00:00:00

  • [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].

    abstract::The biological behaviour of invasive carcinoma of the uterine cervix is not always predictable. It is therefore important to establish new biological markers which could be useful in determining a more reliable prognosis. We have analyzed the c-Ha-ras and c-myc proto-oncogenes in a large series (154 cases) of cervical...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Riou G,Sheng ZM,Zhou D,Lusinchi A,Le Doussal V,Barrois M

    更新日期:1990-01-01 00:00:00

  • An interim assessment of the experience of fast neutron boost in inoperable rectal carcinomas in Orléans.

    abstract::Since January 1981, 58 patients with postoperative recurrences or inoperable rectal cancer have been included in a trial featuring a neutron boost after an initial series of irradiation given by the classical high energy photon procedure. This group irradiated at the Neutrontherapy Unit in Orléans was compared to a hi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Breteau N,Destembert B,Favre A,Sabattier R,Schlienger M

    更新日期:1986-01-01 00:00:00

  • [Prognostic factors in multiple myeloma. Review of the literature].

    abstract::Apparition of new tools in the therapy of multiple (MM) strengthens the need for valuable prognostic categorization of each patient in order to propose the most adequate treatment. Prognostic factors in MM can be divided in four groups. The first, including beta 2 microglobulin (beta 2m), hemopoiesis impairment, osteo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bauduer F,Troussard X,Delmer A

    更新日期:1993-12-01 00:00:00

  • [Changes in methylation of tumor cells: a new in situ quantitative approach on interphase nuclei and chromosomes].

    abstract::DNA methylation is known to be related to the regulation of gene expression. DNA methylation patterns are modified in tumors compared to normal tissue, and in some cases, these variations are linked to cancer progression. Molecular biology techniques are generally used to evaluate DNA methylation status. We describe h...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Veilleux C,Bernardino J,Gibaud A,Niveleau A,Malfoy B,Dutrillaux B,Bourgeois CA

    更新日期:1995-11-01 00:00:00